By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cortice Biosciences 

50 W 57th Street, 15th Floor

New York  New York  10019  U.S.A.
Phone: 646-747-9090 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Cortice Biosciences Announces Acquisition Of Exclusive Rights To A Novel Neurological Disease Therapeutic And Development Platform 7/31/2014 10:43:08 AM
Cortice Biosciences Announces Enrollment Of A Phase 1 Clinical Trial Evaluating TPI 287 In Rare Tauopathy Diseases 7/7/2014 8:21:11 AM
Cortice Biosciences Announces Enrollment Of A Phase 2 Trial Evaluating TPI 287 Plus Avastin® For Treatment Of Glioblastoma Previously Treated With Anti-Angiogenic Therapy 3/20/2014 8:53:03 AM
Cortice Biosciences Announces Enrollment Of A Clinical Trial Targeting Tau Dysfunction In Mild-To-Moderate Alzheimer's Disease 1/22/2014 8:57:47 AM
Cortice Biosciences Announces Enrollment Of A Clinical Trial Targeting Tau Dysfunction In Mild-To-Moderate Alzheimer's Disease 1/21/2014 9:07:19 AM
Cortice Biosciences Announces Enrollment Of A Phase 2 Trial Evaluating TPI 287 Plus Avastin® For Treatment Of Recurrent Glioblastoma Naive To Prior Anti-Angiogenic Therapy 1/9/2014 9:35:51 AM
Cortice Biosciences Hires George Farmer, Ph.D. For CEO Post 1/7/2014 9:10:19 AM
//-->